Drug (if Trial Patent No. Filed Date Lead Pet. Patent Owner(s) Inst. Dec. Outcome Details of FWD applicable) <Information obtained primarily from Lex Machina™ and public sources on the Internet. If any errors are identified, please contact Lisa Mandrusiak at Oblon.> Roche Palo Alto LLC; Helsinn PGR2014-00010 Aloxi® 8,598,219 2-Sep-14 Accord Healthcare, Inc. Healthcare S.A. N/A Settled pre-institution N/A Phenyl-ephrine PGR2015-00011 HCl 8,859,623 11-May-15 Altaire Pharmaceuticals Inc Paragon Biotek, Inc. Instituted Final written decision All inst. claims upheld Innovative Environmental PGR2016-00002 9,126,245 19-Nov-15 Peroxychem LLC Technologies, Inc. Instituted Settled post-institution N/A Dr. Reddy’s Laboratories, PGR2016-00007 Aloxi® 9,173,942 5-Feb-16 Ltd. Helsinn Healthcare S.A. Denied N/A N/A Dr. Reddy’s Laboratories, PGR2016-00008 Aloxi® 9,173,942 5-Feb-16 Ltd. Helsinn Healthcare S.A. Denied N/A N/A Copaxone®, Yeda Research and Development PGR2016-00010 Glatopa® 9,155,776 16-Feb-16 Mylan N.V. Co Ltd. Denied Procedurally dismissed N/A PGR2016-00018 9,091,698 27-Apr-16 B.R.A.H.M.S. France S.A.S. Becton, Dickinson and Company Instituted Settled post-institution N/A Copaxone®, Yeda Research and Development PGR2016-00028 Glatopa® 9,155,776 12-Jul-16 Amneal Pharmaceuticals LLC Co Ltd. N/A Settled pre-institution N/A PGR2016-00042 9,415,105 12-Sep-16 Corvus Pharmaceuticals, Inc. The United States of America Denied Claims disclaimed N/A All inst. claims PGR2017-00008 9,283,239 14-Dec-16 Grunenthal GMBH Antecip Bioventures II LLC Instituted Final written decision unpatentable PGR2017-00011 9,498,419 31-Jan-17 L’Oréal USA, Inc. Liqwd, Inc. Denied N/A N/A All inst. claims PGR2017-00012 9,498,419 31-Jan-17 L’Oréal USA, Inc. Liqwd, Inc. Instituted Final written decision unpatentable Merck Sharp & Dohme PGR2017-00016 9,399,060 22-Mar-17 Corp. Wyeth LLC Denied Procedurally dismissed N/A Merck Sharp & Dohme PGR2017-00017 9,399,060 22-Mar-17 Corp. Wyeth LLC Denied Procedurally dismissed N/A PGR2017-00020 Vectra® DA test 9,387,246 12-Apr-17 Myriad Genetics L. Douglas Graham Denied Claims disclaimed N/A PGR2017-00021 9,402,845 1-May-17 Aradigm Corporation Insmed Incorporated Denied Procedurally dismissed N/A All inst. claims PGR2017-00022 9,408,862 8-May-17 Grünenthal GmbH Antecip Bioventures II LLC Instituted Final written decision unpatentable PGR2017-00033 9,447,360 20-Jun-17 Nippon Suisan Kaisha Ltd. Pronova BioPharma Norge AS Instituted Final written decision All inst. claims Concert Pharmaceuticals, PGR2017-00034 Jakafi®, Jakavi® 9,662,335 27-Jun-17 Inc. Incyte Corporation Denied N/A N/A PGR2017-00039 Qbrelis™ 9,463,183 10-Jul-17 KVK-Tech, Inc. Silvergate Pharmaceuticals Inc. Instituted Procedurally dismissed N/A All inst. claims PGR2018-00001 9,539,268 10-Oct-17 Grünenthal GmbH Antecip Bioventures II LLC Instituted Final written decision unpatentable PGR2018-00006 9,613,186 7-Nov-17 CathWorks Ltd HeartFlow, Inc. N/A Settled pre-institution N/A L'Oréal USA, Inc. and L'Oréal PGR2018-00023 9,668,954 31-Jan-18 S.A. Liqwd, Inc. Denied N/A N/A L'Oréal USA, Inc. and L'Oréal PGR2018-00024 9,668,954 31-Jan-18 S.A. Liqwd, Inc. Denied N/A N/A L'Oréal USA, Inc. and L'Oréal PGR2018-00025 9,668,954 1-Feb-18 S.A. Liqwd, Inc. Instituted Final written decision Some claims upheld Rimfrost New Zealand Ltd.; Emerald Fisheries AS; PGR2018-00033 9,644,170 9-Feb-18 Rimfrost USA, LLC; et al. Aker BioMarine Antarctic AS Denied N/A N/A Purdue Pharma L.P.; Purdue Collegium Pharmaceutical, Pharmaceuticals, LP; The P.F. PGR2018-00048 9,693,961 13-Mar-18 Inc. Laboratories, Inc. Instituted Pending N/A Personal Genome PGR2018-00057 9,840,743 28-Mar-18 Diagnostics, Inc. Guardant Health, Inc. N/A Procedurally dismissed N/A Personal Genome PGR2018-00058 9,834,822 28-Mar-18 Diagnostics, Inc. Guardant Health, Inc. N/A Procedurally dismissed N/A Alnylam U.S., Inc.; Alnylam PGR2018-00059 9,695,423 2-Apr-18 Pharmaceuticals, Inc. Silence Therapeutics GmbH Denied N/A N/A Grunenthal GMBH; Abiogen All inst. claims PGR2018-00062 9,707,245 18-Apr-18 Pharma SpA Antecip Bioventures II LLC Instituted Final written decision unpatentable Alnylam U.S., Inc.; Alnylam PGR2018-00067 9,758,784 11-Jun-18 Pharmaceuticals, Inc. Silence Therapeutics GmbH N/A Settled pre-institution N/A Novartis Pharmaceuticals PGR2018-00069 9,844,539 18-Jun-18 Corp. Plexxicon, Inc. Denied N/A N/A Massachusetts Institute of Technology; The Broad Institute Inc.; Presidents and Fellows of PGR2018-00072 9,790,490 17-Jul-18 Benson Hill Biosystems, Inc. Harvard College Denied N/A N/A Alnylam U.S., Inc.; Alnylam PGR2018-00075 9,783,802 9-Jul-18 Pharmaceuticals, Inc. Silence Therapeutics GmbH N/A Settled pre-institution N/A Alnylam U.S., Inc.; Alnylam PGR2018-00088 9,790,505 17-Jul-18 Pharmaceuticals, Inc. Silence Therapeutics GmbH N/A Settled pre-institution N/A Alnylam U.S., Inc.; Alnylam PGR2018-00089 9,790,501 17-Jul-18 Pharmaceuticals, Inc. Silence Therapeutics GmbH N/A Settled pre-institution N/A Abiogen Pharma SpA; All inst. claims PGR2018-00092 9,820,999 21-Aug-18 Grünenthal GmbH Antecip Bioventures II LLC Instituted Final written decision unpatentable PGR2018-00098 9,840,491 12-Sep-18 Hybrigenics SA Forma Therapeutics, Inc. Instituted Final written decision Some claims upheld Adello Biologics LLC, Apotex Amgen Inc. and Amgen PGR2019-00001 9,856,287 1-Oct-18 Inc., and Apotex Corp. Manufacturing Ltd. Instituted Settled post-institution N/A All inst. claims PGR2019-00002 9,855,302 2-Oct-18 Genome & Co. University of Chicago Instituted Final written decision unpatentable Abiogen Pharma SpA; All inst. claims PGR2019-00003 9,867,839 16-Oct-18 Grünenthal GmbH Antecip Bioventures II LLC Instituted Final written decision unpatentable Jennewein Biotechnologie PGR2019-00023 9,970,018 7-Dec-18 GmbH Glycosyn LLC Denied N/A N/A All inst. claims PGR2019-00026 9,931,352 3-Jan-19 Grunenthal GmbH Antecip Bioventures II LLC Instituted Final written decision unpatentable All inst. claims PGR2019-00027 10,039,774 3-Jan-19 Grunenthal GmbH Antecip Bioventures II LLC Instituted Final written decision unpatentable All inst. claims PGR2019-00028 10,052,338 3-Jan-19 Grunenthal GmbH Antecip Bioventures II LLC Instituted Final written decision unpatentable DUV Intermediate Holding Corp.; LifeScan U.K. Limited; PHC, Inc.; Ikeda Food Research, PGR2019-00031 9,957,543 30-Jan-19 et al. Ltd. Denied N/A N/A DUV Intermediate Holding Corp.; LifeScan U.K. Limited; PHC, Inc.; Ikeda Food Research, PGR2019-00032 9,976,125 30-Jan-19 et al. Ltd. Instituted Claims disclaimed N/A PGR2019-00043 Taltz® 10,011,654 2-Apr-19 Eli Lilly and Co. Genentech, Inc. Instituted Claims disclaimed N/A PGR2019-00044 Taltz® 10,011,654 1-Apr-19 UCB, Inc. Genentech, Inc. Instituted Claims disclaimed N/A Teva Pharmaceuticals USA, PGR2019-00048 Korlym® 10,195,214 7-May-19 Inc. Corcept Therapeutics Inc. Instituted Final written decision All inst. claims upheld Max-Planck-Gesellschaft Zur Progenics Pharmaceuticals, Foerderung der Wissenschaften PGR2019-00052 10,112,974 29-Jul-19 Inc. E.V. and Universitat Zu Koln Instituted Final written decision All inst. claims upheld National University of Singapor; Singapore Health Services PTE PGR2019-00053 10,106,603 23-Jul-19 Lassen Therapeutics 1, Inc. LTD. Denied N/A N/A Galderma Laboratories LP; Nestle Skin Health S.A.; et PGR2019-00062 10,143,728 4-Sep-19 al. Medy-Tox, Inc. Instituted Pending N/A Humira® Fresenius SE & Co. (KGaA.); PGR2019-00064 Amjevita™ 10,155,039 17-Sep-19 Fresenius Kabi AG; et al. Coherus BioSciences Inc. Denied N/A N/A Pharmacosmos A/S; Pharmacosmos PGR2020-00009 10,478,450 6-Jan-20 Therapeutics, Inc. American Regent, Inc. Denied N/A N/A Syngenta Crop Protection PGR2020-00028 10,294,202 21-Feb-20 AG FMC Corporation Instituted Pending N/A PGR2020-00030 10,519,175 6-Jan-20 Kohn Law Firm SC Compass Pathways Ltd. Denied N/A N/A Commonwealth Scientific and Industrial Research PGR2020-00033 10,301,638 28-Feb-20 Organisation BASF Plant Science GmbH Instituted Pending N/A Commonwealth Scientific and Industrial Research PGR2020-00057 10,351,870 16-Apr-20 Organisation BASF Plant Science GmbH Instituted Pending N/A Syngenta Crop Protection Bayer Cropscience PGR2020-00058 10,364,243 30-Apr-20 AG Aktiengesellschaft Instituted Pending N/A PGR2020-00064 Elcys™ 10,478,453 19-May-20 Eton Pharmaceuticals, Inc. Exela Pharma Sciences, LLC Denied N/A N/A PGR2020-00068 Elcys™ 10,583,155 8-Jun-20 Eton Pharmaceuticals, Inc. Exela Pharma Sciences, LLC Denied N/A N/A PGR2020-00070 10,485,257 22-Jun-20 Sweegen, Inc. Purecircle SDN BHD Denied Pending N/A Boehringer Ingelheim Intervet Intl. B.V.; Merck Sharp PGR2020-00076 10,450,351 22-Jul-20 Animal Health USA Inc. & Dohme Corp.; et al. Instituted Pending N/A PGR2020-00086 10,653,719 21-Sep-20 Eton Pharmaceuticals, Inc. Exela Pharma Sciences, LLC N/A Pending N/A Evergreen Theragnostics, Advanced Accelerator PGR2021-00001 10,596,278 2-Oct-20 Inc. Applications S.A. N/A Pending N/A Evergreen Theragnostics, Advanced Accelerator PGR2021-00002 10,596,278 2-Oct-20 Inc. Applications S.A. N/A Pending N/A Evergreen Theragnostics, Advanced Accelerator PGR2021-00003 10,596,276 2-Oct-20 Inc.